✦ LIBER ✦

CHEMOTHERAPY FOR ADVANCED OVARIAN CANCER

✍ Scribed by Omura, GeorgeA.

Book ID: 122393385
Publisher: The Lancet
Year: 1987
Tongue: English
Weight: 168 KB
Volume: 330
Category: Article
ISSN: 0140-6736
DOI: 10.1016/S0140-6736(87)92478-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neoadjuvant Chemotherapy for Advanced Ov

Neoadjuvant Chemotherapy for Advanced Ovarian Cancer

✍ Scott M. Eisenkop; Nick M. Spirtos; Richard L. Friedman 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 25 KB

Neoadjuvant chemotherapy for advanced ov

Neoadjuvant chemotherapy for advanced ovarian cancer

✍ P.E. Schwartz; J.T. Chambers; R. Makuch 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 136 KB

Neoadjuvant Chemotherapy for Advanced Ov

Neoadjuvant Chemotherapy for Advanced Ovarian Cancer

✍ Peter E. Schwartz; Joseph T. Chambers; Robert Makuch 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 295 KB

Intraperitoneal chemotherapy for advance

Intraperitoneal chemotherapy for advanced ovarian cancer

✍ Lucas, William E.; Markman, Maurie; Howell, Stephen S. 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 546 KB

Gold standard chemotherapy for advanced

Gold standard chemotherapy for advanced ovarian cancer

📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 154 KB

Alternating multiagent chemotherapy for

Alternating multiagent chemotherapy for advanced ovarian cancer

✍ Enrique Hernandez; Neil B. Rosenshein; Jose Villar; Michael B. Dillon; David S. 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 344 KB

## Abstract A chemotherapy regimen consisting of hexamethylmelamine (H) 150 mg/ m^2^ orally days 1–14, cyclophosphamide (C) 500 mg/m^2^ IV day 1 of a 28‐day cycle with Adriamycin (A) 40 mg/m^2^ IV day 1 alternating with cisdiamminechloroplatinum (C‐P) 50 mg/m^2^ IV day 1 every other cycle was admin